Laura L. KIESSLING,Darryl A. WESENER,Kittikhun WANGKANONT
申请号：
US14933891
公开号：
US20160131649A1
申请日:
2015.11.05
申请国别(地区):
US
年份:
2016
代理人:
摘要：
The present disclosure provides for methods of diagnosing and treating bacterial infections. Human Intelectin 1 (hIntL-1) has been shown to bind selectively to glycan components on bacteria including Streptococcus pneumonia, Proteus mirabilis, Proteus vulgaris, Klebsiella pneumonia and Yersinia pestis. This interaction can be targeted to identify, purify and therapeutically target such organisms.
